SPINRAZA® (nusinersen) is a prescription medicine used to treat spinal muscular atrophy (SMA) in both adult and pediatric patients—a progressive neuromuscular disease that affects the central nervous system and leads to motor function loss over time.

This was extra fun for me because I’m a neuroscience nerd. SPINRAZA was the first brand I worked on after a brief stint in managed markets, and I jumped in headfirst. I owned the claims library, helped refine core messaging, and deepened my understanding of both the science and the client’s vision.